| 12/21/2004 | CVHY | Moody's confirms Apogent convertible
|
| 9/20/2004 | CV | Apogent Technologies calls $299.8 million convertibles
|
| 8/3/2004 | CV | Fisher Scientific says almost all Apogent convertibles exchanged
|
| 8/3/2004 | HY | Apogent, Fisher Scientific complete tender offer for 61/2% notes
|
| 7/27/2004 | HY | Apogent says 99.8% of 61/2% notes tendered by consent deadline
|
| 7/13/2004 | CV | Fisher Scientific extends exchange for Apogent's convertibles, increases fees
|
| 7/13/2004 | HY | Apogent extends tender offer for 61/2% notes, ups payment
|
| 7/2/2004 | CV | Fisher Scientific extends exchange for Apogent's convertibles to July 16
|
| 7/2/2004 | HY | Apogent extends tender offer for 61/2% notes
|
| 6/18/2004 | HY | Apogent again extends consent deadline for 61/2% notes, coincides with tender expiration
|
| 6/15/2004 | CV | Apogent contingent convertibles become convertible
|
| 6/14/2004 | HY | Apogent extends consent deadline for 61/2% notes
|
| 5/28/2004 | CV | Fisher starts exchange for Apogent convertibles
|
| 5/28/2004 | HY | Apogent tenders for 61/2% notes
|
| 5/26/2004 | CV | Lehman analyst: Sweetener for Apogent convertibles exchange offer could be argued
|
| 5/26/2004 | CV | Fisher plans exchange for Apogent convertibles
|
| 3/23/2004 | CV | Merger could be negative for Apogent converts, positive for Fisher Scientific, Merrill analyst says
|
| 3/17/2004 | CV | Market Commentary: Cytyc goes to 104.375; XL prices at tight end of revised talk; Saks, Greater Bay, CommScope appear
|
| 3/17/2004 | HY | Market Commentary: American Achievement, Riverdeep deals price; Fisher Scientific up on Apogent acquisition news
|
| 3/17/2004 | BKCVHY | Apogent to get new credit facility to refinance bank debt, bonds and convertibles
|
| 1/1/2004 | CV | Apogent greenshoe exercised, raising convertibles to $345 million
|
| 12/12/2003 | CV | S&P rates new Apogent convertibles BBB-
|
| 12/12/2003 | CV | Market Commentary: A dozen new deals this week put $4.64 billion into market; all of Friday's deals higher
|
| 12/12/2003 | CV | Apogent sells $300 million convertible floaters at Libor minus 125 bps, up 42%
|
| 12/11/2003 | CV | Apogent $300 million overnight convertible floater talked at Libor minus 100-150 bps, up 40-44%
|
| 12/11/2003 | CV | Market Commentary: CenterPoint bid 0.125 over par in gray market; Wyeth rises to 101.875; Citizens soars on sale possibility
|
| 10/16/2003 | HY | Apogent offer expires with $318 million 8% notes tendered
|
| 9/25/2003 | HY | Universal Hospital Services tenders for 101/4% notes
|
| 9/16/2003 | BK | Apogent Technologies to use revolver debt to fund tender offer
|
| 9/16/2003 | HY | Apogent tenders for 8% notes
|
| 8/15/2003 | HY | Market Commentary: Market sleep-walks through short post-blackout session, ponders outflow; Dex deal downsized
|
| 8/11/2003 | BKHY | S&P raises Alcatel outlook
|
| 5/22/2003 | HY | Market Commentary: Seven deals price; Triton PCS up on tender news; $257.7 million outflow is funds' first in weeks
|
| 5/22/2003 | HY | New Issue: Apogent Technologies sells $250 million 10-year notes to yield 61/2%
|
| 5/20/2003 | HY | Apogent $250 million 10-year notes talked at 61/2%-63/4%, pricing Thursday
|
| 5/20/2003 | HY | Market Commentary: El Paso, Rhodia price mega-deals; Hard Rock, others also appear; new-deals dominate secondary
|
| 5/13/2003 | CV | S&P ups Quest Diagnostics
|
| 5/13/2003 | HY | Apogent to launch $250 million 10-year deal on Wednesday
|
| 5/13/2003 | HY | Market Commentary: Muzak, Rite Aid price deals; secondary still muted
|
| 5/13/2003 | BKHY | S&P rates Vertis notes B-
|
| 5/9/2003 | CV | Moody's rates new Starwood convert at Ba1
|
| 5/9/2003 | HY | S&P puts Prestolite on positive watch
|
| 4/25/2003 | HY | Apogent Technologies to bring $250 million 10-year notes in first half of May
|
| 4/25/2003 | HY | Market Commentary: Firm tone continues; asbestos names up as deal seen near; Cinemark brings $210 million add-on
|
| 4/23/2003 | CV | S&P ups Rite Aid corporate credit rating
|
| 10/11/2001 | CV | Apogent convertibles increase to $300 mln on greenshoe exercise
|
| 10/5/2001 | CV | New Issue: Apogent converts upsized to $250 mln, yield 2.25%, up 32%
|
| 10/5/2001 | CV | Market Commentary: Convertibles market flat overall, but new issues gain ground
|
| 10/4/2001 | CV | Market Commentary: Convertibles pull back but new deal activity spurs trading
|
| 10/4/2001 | CV | Apogent $200 mln convertibles talked at 2.25%-2.75% yield, up 28%-32%
|
| 10/4/2001 | CV | Convertibles issuance bursts open, contingent features prevail
|
